🔗 Share this article

Chancellor Reeves has revealed she is planning "focused measures to tackle cost of living pressures" in next month's Budget.

During an interview with media outlets, she noted that curbing inflation is a collective duty of both the government and the central bank.

The United Kingdom's price growth is forecast to be the highest among the G7 advanced economies this year and the following year.

Potential Energy Bill Interventions

Sources suggest the administration could take action to bring down utility costs, such as by slashing the present 5% level of value-added tax charged on energy supplies.

A further option is to cut some of the regulatory levies presently added to bills.

Fiscal Limitations and Analyst Predictions

The administration will obtain the latest assessment from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for these measures.

The consensus from the majority of economists is that Reeves will have to introduce higher taxes or budget cuts in order to meet her declared debt limits.

Previously on the same day, analysis suggested there was a £22 billion deficit for the chancellor to address, which is at the lower end of projections.

"There's a collective job between the central bank and the administration to further reduce some of the sources of price increases," the Chancellor stated to the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Tax Commitments and International Concerns

While a great deal of the attention has been on probable tax rises, the chancellor said the latest information from the fiscal watchdog had not changed her vow to campaign commitments not to raise tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing international and commercial concerns for the Budget revenue measures, likely to be focused on those "with the broadest shoulders."

International Economic Tensions

Referring to worries about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests invariably take priority."

Recent announcement by Chinese authorities to increase export controls on rare earths and other resources that are essential for advanced tech production led US President the US President to threaten an extra 100% import tax on imports from China, raising the risk of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary described China's decision "commercial pressure" and "a international production power grab."

Asked about accepting the American proposal to participate in its conflict with China, Reeves said she was "extremely troubled" by China's actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "bad for the global economy and causes additional headwinds."

"In my view there are areas where we need to confront China, but there are also significant chances to sell into China's economy, including banking sector and other areas of the economy. We've got to achieve that equilibrium appropriate."

The chancellor also confirmed she was working with other major economies "regarding our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

The Chancellor also recognized that the cost the National Health Service spends on pharmaceuticals could increase as a result of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and capital.

A number of the world's largest drug companies have said lately that they are either pausing or abandoning projects in the UK, with some attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the price the health service pays for medicines would must increase to prevent companies and pharmaceutical investment leaving the United Kingdom.

Reeves told media: "It has been observed because of the cost structure, that medical research, new drugs have not been offered in the UK in the manner that they are in other EU nations."

"We want to ensure that patients receiving care from the NHS are can receive the top life-saving medicines in the globe. And so we are looking at all of that, and... aiming to obtain additional investment into Britain."